Porter ML, Martorell A, Sayed CJ, Bechara FG, et al. Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials. Nat Med 2026;32:3071-3081.
PMID: 42493571